The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $117.92

Today's change+0.78 +0.67%
Updated February 27 3:14 PM EST. Delayed by at least 15 minutes.
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $117.92

Today's change+0.78 +0.67%
Updated February 27 3:14 PM EST. Delayed by at least 15 minutes.

Abiomed Inc Hits New 20-day High

Abiomed Inc is up today by (U.S.)$0.78 or 0.67% to (U.S.)$117.92 and setting a new 20-day high. Over the last five days, shares have gained 1.16% and 4.65% year to date. Shares have outperformed the S&P 500 by 24.49% during the last year.

Key company metrics

  • Open(U.S.) $117.36
  • Previous close(U.S.) $117.14
  • High(U.S.) $118.84
  • Low(U.S.) $116.55
  • Bid / Ask(U.S.) $117.92 / (U.S.) $117.98
  • YTD % change+4.65%
  • Volume614,184
  • Average volume (10-day)399,472
  • Average volume (1-month)482,191
  • Average volume (3-month)544,417
  • 52-week range(U.S.) $79.62 to (U.S.) $132.95
  • Beta0.50
  • Trailing P/E109.89×
  • P/E 1 year forward99.46×
  • Forward PEG3.90×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.07
Updated February 27 3:14 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.63%

Based on its net profit margin of 11.63%, Abiomed Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.29%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue11510310394
Total other revenue--------
Total revenue11510310394
Gross profit96868879
Total cost of revenue19171515
Total operating expense89888274
Selling / general / administrative54535145
Research & development16181614
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income25152120
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax26152120
Income after tax1591311
Income tax, total10699
Net income1591311
Total adjustments to net income--------
Net income before extra. items1591311
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1591311
Inc. avail. to common incl. extra. items1591311
Diluted net income1591311
Dilution adjustment----0--
Diluted weighted average shares45454545
Diluted EPS excluding extraordinary itemsvalue per share0.340.200.290.24
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.340.200.290.24